This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Rheum Dis 2004; 63: 974–981.
Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54: 3750–3760.
Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, Mayes MD et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004; 31: 2513–2516.
Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis. Resolution in dermal fibrosis. Arthritis Rheum 2006; 54: 1982–1986.
Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y . Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603–610.
Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S et al. In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. Blood 2000; 96: 2419–2425.
Wang B, Yamamoto Y, El-Badri NS, Good RA . Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc Nat Acad Sci USA 1999; 96: 3012–3016.
Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.
Marmont AM, Gualandi F, van Lint MT, Bacigalupo A . Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: 399–402.
Burt RK, Oyama Y, Verda L, Quigley K, Brush M, Yaung K et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50: 2466–2470.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Loh, Y., Oyama, Y., Statkute, L. et al. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?. Bone Marrow Transplant 39, 435–437 (2007). https://doi.org/10.1038/sj.bmt.1705611
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705611
This article is cited by
-
Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis
Bone Marrow Transplantation (2022)
-
Allogene hämatopoetische Stammzelltransplantation
Zeitschrift für Rheumatologie (2016)
-
Emerging concepts in haematopoietic cell transplantation
Nature Reviews Immunology (2012)
-
Long-term follow-up after nonmyeloablative allogeneic hematopoietic stem cell transplantation for systemic sclerosis
Clinical Rheumatology (2008)